Beta Bionics CEO Saint Sean sold 5,641 shares at $20.08 per share on September 3, leaving 398,429 shares after the transaction. The disclosed post-sale holding gives investors a direct view of the president and CEO’s remaining stake in Beta Bionics following the executive share sale.

Key Highlights

  • The transaction was dated September 3, 2026.
  • Saint Sean was identified as Beta Bionics’ President and CEO.
  • His reported ownership after the sale stood at 398,429 shares.

Beta Bionics, Inc. (NASDAQ: BBNX) President and CEO Saint Sean sold 5,641 shares at $20.08 per share. The transaction was dated September 3, 2026, and the disclosed post-sale holding was 398,429 shares.

Beta Bionics CEO’s Remaining Stake

The sale price applied to each of the 5,641 shares transferred. The company’s reported transaction date was September 3, 2026. After the sale, Saint Sean held 398,429 shares of Beta Bionics.